Table 3 Up to 40 men’s population prostate cancer screening costs with two strategies (USD)
From: A cost-benefit analysis of mass prostate cancer screening
Subject | Amount ($) All Men | Â |
|---|---|---|
| Â | Screening by PSA | Screening by PSA and DRE |
Screening Medical Cost | Â | Â |
PSA Test | 30,193,845 | 33,573,915 |
Biopsy & complication | 15,088,842 | 3,370,128 |
Treatment & complication | 37,173,353 | 11,767,247 |
Total Direct Medical Cost | 82,456,040 | 48,711,289 |
Screening non-Medical Cost | Â | Â |
Direct Non-Medical Treatment Costs | 12,623,136 | 13,144,348 |
Direct Non-Medical Diagnosis Costs | 9,404,005 | 9,170,034 |
Total Direct Non-Medical Costs | 22,027,140 | 22,314,382 |
Total Costs | 104,483,181 | 71,025,671 |
Average Cost of Screening per man | 10 | 7 |